References
- Buschle M, Campana D, Carding SR, Richard C, Hoffbrand AV, Brenner MK. Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J Exp Med 1993;177:213–8.
- Williams GT. Programmed cell death: Apoptosis and oncogenesis. Cell 1991;65:1097–8.
- Vitolo U, Ferreri AJ, Zucca E. Primary testicular lymphoma. Crit Rev Oncol Hematol 2008;65:183–9.
- Bart J, Groen HJ, van der Graaf WT, Hollema H, Hendrikse NH, Vaalburg W, . An oncological view on the blood-testis barrier. Lancet Oncol 2002;3:357–63.
- Dal Secco V, Riccioli A, Padula F, Ziparo E, Filippini A. Mouse Sertoli cells display phenotypical and functional traits of antigen-presenting cells in response to interferon gamma. Biol Reprod 2008;78:234–42.
- Stark GR, Kerr IM, Willams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem 1998;67:227–64.
- Asao H, Fu XY. Interferon-gamma has dual potentials in inhibiting or promoting cell proliferation. J Biol Chem 2000;275:867–74.
- Murr C, Fuith LC, Widner B, Wirleitner B, Baier-Bitterlich G, Fuchs D. Increased neopterin concentrations in patients with cancer: Indicator of oxidative stress? Anticancer Res 1999;19:1721–8.
- Bos JL. The ras gene family and human carcinogenesis. Mutat Res 1988;195:255–71.
- Maki A, Berezesky IK, Fargnoli J, Holbrook NJ, Trump BF. Role of [Ca2 + ]i in induction of c-fos, c-jun, and c-myc mRNA in rat PTE after oxidative stress. FASEB J 1992;6:919–24.